Jason T Romancik

15PUBLICATIONS
118CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursAutoimmunityPredictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jan 05, 2026
Time of day of CAR T-cell infusion and outcomes in large B-cell lymphoma.

Danny Luan, Ori Ben Valid, Ofrat Beyar-Katz

|Nov 07, 2025
Outcomes for CART as 2L vs 3L vs 4L or beyond in aggressive B-cell lymphoma: real-world evidence from the ABC Consortium.

John S Wang, Brandon L Ellsworth, Megan Melody

|Oct 22, 2025
Outcomes of bispecific antibodies after CAR T-cell failure for large B-cell lymphoma: results from the ABC consortium.

Megan Melody, Natalie Grover, Stephanie Franco

|Aug 08, 2025
Subsets of follicular lymphoma 3B have divergent outcomes: results from the prospective multicenter MER and LEO cohorts.

Patrizia Mondello, Brianna Negaard, Andrew L Feldman

|Jul 29, 2025
Real World Outcomes of Patients with Aggressive Lymphoma and Autoimmune Disease Treated with CART.

Nicole J Altomare, Megan M Herr, Nisha M Nair

|Mar 27, 2025
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.

Reem Karmali, Geoffrey Shouse, Pallawi Torka

Pageof 3

Frequent Collaborators

10 joint publications

Reem Karmali

8 joint publications

Thomas Ollila

7 joint publications

Narendranath Epperla

7 joint publications

Leo I Gordon